+
AfterRaise/Companies/Halden Bio

Halden Bio

UKCambridgeBiotech & PharmaSeries A
Preview company. Halden Bio is a fictional company written so the network can be seen working before real members fill it. Every real company on AfterRaise carries sourced funding facts instead.

Overview

Where Halden Bio is now

Protein degradation therapeutics for autoimmune disease. Two programmes in lead optimisation, first IND targeted for late 2027.

Latest round
Series A
Amount
£18M
Announced
28 June 2026
Headquarters
Cambridge, UK
Sector
Biotech & Pharma
Followers
268
Signals in 30 days
2

Current direction Preview

What this company is working on

Preclinical scale-upRegulatoryLab expansion

Momentum Preview

AfterRaise Score

74
Building momentum
2 signals in the last 30 days

Momentum on a preview company is illustrative. On a real company it is computed only from funding facts we hold, and every component is shown.

Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 21 August 2026
    Taking 9,000 sq ft of lab space on the Babraham campus.
    Expansion
  • 26 July 2026
    Dr Anneke Visser joins the scientific advisory board.
    Leadership

Moves

Published by the company

Share a Move
MoveExpansionPreview7 days ago
Halden Bio
Series A · Cambridge, UK · Biotech & Pharma
What happened

Taking 9,000 sq ft of lab space on the Babraham campus.

We move in November. It roughly triples our bench capacity and lets us bring the assay work back in-house from a CRO.

What nextSix lab hires, and equipment procurement that has to land before the fit-out finishes.
Where you helpLab scientistsEquipment suppliersFacilities project management
TalentService providersAdvisersMedia
Company room
MoveLeadershipPreview33 days ago
Halden Bio
Series A · Cambridge, UK · Biotech & Pharma
What happened

Dr Anneke Visser joins the scientific advisory board.

Anneke ran translational medicine for two autoimmune programmes that reached phase two. She will chair our IND readiness reviews.

What nextTwo more advisers, specifically on regulatory strategy for the EU and US.
Where you helpRegulatory advisoryScientific advisory
AdvisersRecruitersMedia
Company room

Opportunities

Work this company has opened

OpportunitySUPPLIER NEEDPreview7 days ago
Halden Bio
Cambridge, UK · On site · Firm

Lab fit-out and equipment procurement

Fit out 9,000 sq ft on the Babraham campus and procure automation for assay work moving in-house.

Who they wantSuppliers and project managers with life science fit-out experience in the Cambridge cluster.
TalentAdvisersService providersInvestorsMedia
Company room

Open to

Who may approach Halden Bio

Open to
TalentAdvisersService providersInvestors
Not currently accepting
Media

Declared These are the company's own settings. AfterRaise does not offer an approach the company has declined.

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to Halden Bio.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.